Clinical Trial Update: Omacor Plus Standard Therapies In Post Myocardial Infarction (MI) Subjects Evaluation: The OPTIMISE Observational Study

View source ↗

Summary

Observational study update evaluating Omacor Plus standard therapies in post-myocardial infarction patients; study completed with posted results in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Omacor (omega-3-acid ethyl esters)

Snippet

Sponsor: Mylan Inc. | Conditions: Myocardial Infarction (MI) | Status: COMPLETED | Results posted: 2016-05-09